You might get some valuable input over there. I think Biomaven once followed Polymedix, and others may have some insights. The CTIX board looks too congested to sift through, so may not be especially useful.
For myself I only follow CTIX loosely for the Brilacidin / defensin mimetics angle, so am far from an expert on the company. Just glad to see the technology moving ahead.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.